Enhancement of Vaccine-Induced T-Cell Responses by PD-L1 Blockade in Calves

被引:0
|
作者
Okagawa, Tomohiro [1 ]
Konnai, Satoru [1 ,2 ,3 ]
Nakamura, Hayato [2 ]
Ganbaatar, Otgontuya [2 ]
Sajiki, Yamato [2 ]
Watari, Kei [2 ]
Noda, Haruka [4 ]
Honma, Mitsuru [4 ]
Kato, Yukinari [5 ,6 ]
Suzuki, Yasuhiko [1 ,3 ,7 ,8 ]
Maekawa, Naoya [1 ]
Murata, Shiro [1 ,2 ]
Ohashi, Kazuhiko [1 ,2 ,9 ]
机构
[1] Hokkaido Univ, Fac Vet Med, Dept Adv Pharmaceut, Sapporo 0600818, Japan
[2] Hokkaido Univ, Fac Vet Med, Dept Dis Control, Sapporo 0600818, Japan
[3] Hokkaido Univ, Inst Vaccine Res & Dev HU IVReD, Sapporo 0010021, Japan
[4] Snow Brand Seed Co Ltd, Hokkaido Res Stn, Naganuma 0691464, Japan
[5] Tohoku Univ, Dept Antibody Drug Dev, Grad Sch Med, Sendai 9808575, Japan
[6] Tohoku Univ, Dept Mol Pharmacol, Grad Sch Med, Sendai 9808575, Japan
[7] Hokkaido Univ, Int Inst Zoonosis Control, Div Bioresources, Sapporo 0010020, Japan
[8] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Global Stn Zoonosis Control, Sapporo 0010020, Japan
[9] Hokkaido Univ, Fac Vet Med, Int Affairs Off, Sapporo 0600818, Japan
关键词
PD-L1; PD-1; T cell; live attenuated vaccine; immunotherapy; cattle; RESPIRATORY SYNCYTIAL VIRUS; VIRAL-DIARRHEA-VIRUS; IMMUNE-RESPONSE; GAMMA-DELTA; INFECTION; ANTIBODY; IFN; IMMUNOLOGY; EXHAUSTION; CD4;
D O I
10.3390/vaccines11030559
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interactions between programmed death 1 (PD-1) and PD-ligand 1 (PD-L1) cause functional exhaustion of T cells by inducing inhibitory signals, thereby attenuating effector functions of T cells. We have developed an anti-bovine PD-L1 blocking antibody (Ab) and have demonstrated that blockade of the interaction between PD-1 and PD-L1 reactivates T-cell responses in cattle. In the present study, we examined the potential utility of PD-1/PD-L1-targeted immunotherapy in enhancing T-cell responses to vaccination. Calves were inoculated with a hexavalent live-attenuated viral vaccine against bovine respiratory infections in combination with treatment with an anti-PD-L1 Ab. The expression kinetics of PD-1 in T cells and T-cell responses to viral antigens were measured before and after vaccination to evaluate the adjuvant effect of anti-PD-L1 Ab. PD-1 expression was upregulated in vaccinated calves after the administration of a booster vaccination. The activation status of CD4(+), CD8(+), and gamma delta TCR+ T cells was enhanced by the combination of vaccination and PD-L1 blockade. In addition, IFN-gamma responses to viral antigens were increased following combinatorial vaccination with PD-L1 blockade. In conclusion, the blockade of the PD-1/PD-L1 interaction enhances T-cell responses induced by vaccination in cattle, indicating the potential utility of anti-PD-L1 Ab in improving the efficacy of current vaccination programs.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Analysis of PD-1, PD-L1, and T-cell infiltration in angiosarcoma pathogenetic subgroups
    Tomassen, T.
    Weidema, M. E.
    Hillebrandt-Roeffen, M. H. S.
    van der Horst, C.
    Desar, I. M. E.
    Flucke, U. E.
    Versleijen-Jonkers, Yvonne M. H.
    IMMUNOLOGIC RESEARCH, 2022, 70 (02) : 256 - 268
  • [32] PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer
    Bocanegra, Ana
    Fernandez-Hinojal, Gonzalo
    Zuazo-Ibarra, Miren
    Arasanz, Hugo
    Jesus Garcia-Granda, Maria
    Hernandez, Carlos
    Ibanez, Maria
    Hernandez-Marin, Berta
    Martinez-Aguillo, Maite
    Jose Lecumberri, Maria
    Fernandez de Lascoiti, Angela
    Teijeira, Lucia
    Morilla, Idoia
    Vera, Ruth
    Escors, David
    Kochan, Grazyna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07):
  • [33] The regulation of PD-L1 expression by miRNAs in cutaneous T-cell lymphoma
    Querfeld, Christiane
    Estephan, Renee
    Kil, Sung Hee
    Rosen, Steven T.
    EUROPEAN JOURNAL OF CANCER, 2018, 101 : S9 - S9
  • [34] PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness
    Chen, Xiangyu
    Lin, Yao
    Yue, Shuai
    Yang, Yang
    Yang, Xiaofan
    He, Junjian
    Gao, Leiqiong
    Li, Zhirong
    Hu, Li
    Tang, Jianfang
    Wang, Yifei
    Tian, Qin
    Hao, Yaxing
    Xu, Lifan
    Huang, Qizhao
    Cao, Yingjiao
    Ye, Lilin
    VACCINE, 2023, 41 (34) : 4986 - 4995
  • [35] PD-L1 expression in human hepatocytes induces T-cell apoptosis
    Mühlbauer, M
    Fleck, M
    Weiss, T
    Froh, M
    Schütz, C
    Blank, C
    Schölmerich, J
    Hellerbrand, C
    MEDIZINISCHE KLINIK, 2006, 101 (04) : A23 - A23
  • [36] Renal tubular PD-L1 (CD274) suppresses alloreactive human T-cell responses
    Starke, Astrid
    Lindenmeyer, Maja T.
    Segerer, Stephan
    Neusser, Matthias A.
    Ruesi, Barbara
    Schmid, Daniel M.
    Cohen, Clemens D.
    Wuethrich, Rudolf P.
    Fehr, Thomas
    Waeckerle-Men, Ying
    KIDNEY INTERNATIONAL, 2010, 78 (01) : 38 - 47
  • [37] Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours
    Han Yao
    Jiang Lan
    Chushu Li
    Hubing Shi
    Jean-Philippe Brosseau
    Huanbin Wang
    Haojie Lu
    Caiyun Fang
    Yao Zhang
    Lunxi Liang
    Xiaolin Zhou
    Chaojun Wang
    Yu Xue
    Yun Cui
    Jie Xu
    Nature Biomedical Engineering, 2019, 3 : 414 - 414
  • [38] Evolving insights into the improvement of adoptive T-cell immunotherapy through PD-1/PD-L1 blockade in the clinical spectrum of lung cancer
    Li, Yutao
    Sharma, Amit
    Schmidt-Wolf, Ingo G. H.
    MOLECULAR CANCER, 2024, 23 (01)
  • [39] Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity
    Emmelot, Maarten E.
    Bodewes, Rogier
    Maissan, Cyril
    Vos, Martijn
    de Swart, Rik L.
    van Els, Cecile A. C. M.
    Kaaijk, Patricia
    NPJ VACCINES, 2025, 10 (01)
  • [40] Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer
    Huang, Kevin Chih-Yang
    Chiang, Shu-Fen
    Chen, William Tzu-Liang
    Chen, Tsung-Wei
    Hu, Ching-Han
    Yang, Pei-Chen
    Ke, Tao-Wei
    Chao, K. S. Clifford
    CANCERS, 2020, 12 (02)